Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Singapore ETF (EWS) vs 22nd Century Group Inc (XXII) Price & Performance

iShares MSCI Singapore ETFTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Singapore ETF vs 22nd Century Group Inc — how do they compare? iShares MSCI Singapore ETF trades at $31.78, while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). Which is the better fit depends on your goals.

EWSXXII
Sector
Broad Market / FactorTechnology
52-Week High
$32.09$1.47K
52-Week Low
$26.47$3.90
Market Cap
$1.52M
Enterprise Value
-$6.71M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Singapore ETF

EWS trades at $31.825, up 0.62% with strong technical momentum as moving averages signal bullish alignment. The ETF benefits from Singapore's economic resilience and AI-driven growth narrative, though key financial ratios remain undisclosed. Recent news highlights Singapore's strategic positioning in Asian markets and financial sector strength, with a dividend of $0.52 scheduled for June 2026.

Outlook remains positive given technical strength and regional economic tailwinds, but overbought RSI readings suggest near-term consolidation risk. The concentrated financials exposure (54% of holdings) ties performance to banking sector stability, while AI infrastructure investments offer growth catalysts. Investors should monitor Singapore's economic policies and global market volatility.

22nd Century Group Inc

22nd Century Group (XXII) trades at $4.33, up 3.34% on the day, following a recent 20:1 reverse stock split. The stock shows a bearish technical signal with support at $4 and resistance at $5. Fundamentally, the company continues to operate at a loss with negative gross and net profit margins, though revenue reached $7.05M in 2025. Recent news highlights aggressive expansion of its VLN reduced-nicotine cigarette brand into California and New York markets.

The outlook remains speculative with significant execution risk. While analyst consensus is strongly bullish (75% buy ratings), the company must demonstrate a path to profitability through its VLN product expansion. Key risks include persistent cash burn, competitive tobacco market pressures, and regulatory uncertainty. The stock represents a high-risk, high-potential turnaround play dependent on commercial success of its reduced-nicotine platform.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares MSCI Singapore ETF

EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.

Read more on EWS

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII